Primate experiments at Columbia University

Retrieved on:

Thursday, April 14, 2022

Diabetes, Pharmaceutical, Health, Center, Korea Disease Control and Prevention Agency, Severe cognitive impairment, Eye, Risk, Retinopathy, Visual acuity, Diabetes, Columbia University, Patient, Retina, Growth, The International Agency for the Prevention of Blindness, Optic disc, Visual impairment, PDR, Organic, Diabetic retinopathy, Primate experiments at Columbia University, Blood, Cerebral edema, Prevalence, Pharmaceutical industry

Proliferative diabetic retinopathy is the most advanced stage of diabetic retinopathy which is characterized by the growth of new vessels on the surface of the retina.

Key Points:

Proliferative diabetic retinopathy is the most advanced stage of diabetic retinopathy which is characterized by the growth of new vessels on the surface of the retina.
Hence, the rising prevalence of diabetes is directly contributing to the further increase in the prevalence of proliferative diabetic retinopathy (PDR).
North America is expected to hold a major market share in the global proliferative diabetic retinopathy market due to rising prevalence of diabetes and diabetic retinopathy and availability of advanced technology and minimally invasive laser technique in this region.
According to the Centers for Disease Control and Prevention, approximately 4.2 million adults had diabetic retinopathy and 655,000 had vision-threatening diabetic retinopathy.